Martha E. Vincent

Chief Tech/Sci/R&D Officer at Agensys, Inc.

Consumer Services

Commercial Services

Health Technology

Profile

Martha E.
Vincent is currently the Vice President of Clinical Research & Development at Agensys, Inc. Prior to this, she was the VP of Medical Affairs & Clinical Development at Amgen, Inc. from 1995 to 2004.
Dr. Vincent holds a doctorate degree from the University of Medicine & Dentistry of New Jersey and an undergraduate degree from Iowa State University.

Martha E. Vincent active positions

Companies	Position	Start
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.	Chief Tech/Sci/R&D Officer	31/12/2003

All active positions of Martha E. Vincent

Former positions of Martha E. Vincent

Companies	Position	End
AMGEN INC.	Chief Tech/Sci/R&D Officer	31/12/2003

See the detail of Martha E. Vincent's experience

Training of Martha E. Vincent

Iowa State University	Undergraduate Degree
University of Medicine & Dentistry of New Jersey	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martha E. Vincent's experience

Connections

100 +

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
AMGEN INC.	Health Technology

Private companies	1
Agensys, Inc. Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA.	Commercial Services